Vertex Pharmaceuticals(us:VRTX)

484.74

-0.02%

Updated on 2025-04-02

Open:486.27
Close:484.74
High:491.93
Low:480.95
Prev Close:484.82
Volume:1.25M
Turnover:606.25M
Turnover Ratio:0.49%
Shares:256.79M
MarketCap:124.48B

About Vertex Pharmaceuticals

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Company Name: Vertex Pharmaceuticals
Address: 50 Northern Avenue
Employees: 5400
Fiscar Year: 12-31
IPO Date: 1991-07-04
CIK: 875320

View all SEC Filings

About

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Address:50 Northern Avenue

Market Movers